ARCT Message Board Post 10926382 | Arcturus Therapeutics...
home / stock / arct / arct message board
(investorshangout)
Posted on: Jul/28/2021 20:35:55
Source: investorshangout
https://investorshangout.com/post/view?id=6199820
whytestocks: $ARCT News Article - Arcturus Announces Regulatory Approval to Proceed with Phase 2 Study of ARCT-81
News, Short Squeeze, Breakout and More Instantly...
Arcturus Therapeutics Ltd. Company Name:
ARCT Stock Symbol:
Market:
Arcturus Therapeutics Ltd. Website:
-
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, toda...
-
2024-07-02 10:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for ARCT on July 2, 2024 08:19AM ET. The previous analyst recommendation was Overweight. ARCT was trading at $23.66 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
-
ARCT-810 Phase 2 study completed enrollment at 0.3 mg/kg dose level in Europe with data expected later this year ARCT-810 to expand Phase 2 clinical program in the U.S. to enroll patients with more severe disease ARCT-032 IND for Phase 2 multiple ascending dose study to be submitt...